Niranib 100mg (Niraparib) is an advanced oral medication used for the maintenance treatment of ovarian, fallopian tube, and primary peritoneal cancers. It's part of a group of cancer treatments known as PARP inhibitors, which target and destroy cancer cells by preventing them from repairing their DNA. Niranib offers new hope for patients who are in remission following successful treatment with…
Olanib 50mg & 150mg (Olaparib) is a leading-edge oral medication used to treat various cancers, specifically ovarian, breast, prostate, and pancreatic cancers. This powerful drug belongs to a class of treatments known as PARP Inhibitor For Prostate Cancer (Poly ADP-Ribose Polymerase inhibitors). It is designed to stop cancer cells from repairing themselves, slowing tumour growth and enhancing survival rates.
